Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2172-2017Class II

Ellex Tango Reflex with slit lamp Laser Ophthalmic In the SLT mode, the device is intended to be used for...

Ellex Medical Pty Ltd / initiated 2017-04-04 / Terminated / root cause: design

Laserex Systems Inc. began a recall of Ellex Tango Reflex with slit lamp Laser Ophthalmic In the SLT mode, the device is intended to be used for selective laser trabeculoplasty (ST) operations... on . FDA classified it as Class II and gives the reason as "It was discovered the unit produced a laser emission without pressing the fire button when the slit-lamp was driven to its lowest position prior to use on any patient". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-2172-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Ellex Medical Pty Ltd
Product
Ellex Tango Reflex with slit lamp Laser Ophthalmic In the SLT mode, the device is intended to be used for selective laser trabeculoplasty (ST) operations (laser trabeculoplasty for primary open angle glaucoma). In the VAG mode it is intended to be used to perform procedures requiring the rupture of tissue in the eye for Iridotomy and Iridectomy, Posterior capsulotomy and Posterior membranectomy.
Product code
GEX Powered Laser Surgical Instrument
Reason for recall
It was discovered the unit produced a laser emission without pressing the fire button when the slit-lamp was driven to its lowest position prior to use on any patient.
Root cause tag
design
FDA root cause
Device Design
Action
Ellex Medical shall, without charge, remedy the defect or bring the product into compliance with each applicable Federal standard. 1. Installation of a spacer/collar to prevent the slit lamp from being lowered to the point where the cable can be crushed, 2. Improvement of cable management, 3. The corrections will be conducted at no cost to the purchaser, and 4. The corrective action will be completed by June 30, 2017. Notification of all dealers and purchasers is to be made within 15 working days of receipt of this letter in the manner specified in 21 CFR 1003.21 and 1003.22. This office and the Food and Drug Administration (FDA) district office coordinator noted below are to be included in the notification. For further questions, please call (800) 824-7444.
Quantity in commerce
83
Distribution
US Distribution
Product codes and lots
Serial No: TR 0010, TR 0095

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2172-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2172-2017Class IITerminatedFDA Mandated